Two New Jersey health systems are moving toward a potential combination. Hackensack Meridian Health and Hunterdon Health signed a letter of intent to merge after both boards voted to proceed, according to a joint announcement Monday.
The letter remains nonbinding and doesn’t constitute a final deal. No immediate changes are planned at either organization while both work toward a definitive agreement.
Much still needs to happen before anything is official.
Hunterdon’s interim president and CEO Kristy Alfano called it the “beginning of the next step in a thorough and length process.” She replaces current CEO Patrick Gavin when he retires at the end of this month.
Related: Employers to shift more health costs to workers
Hunterdon Isn’t Looking for a Rescue
Unlike many regional hospitals across the U.S. forced to sell to stay afloat, Hunterdon isn’t coming to the table from a position of weakness. The system is on stable footing. It oversees more than 30 medical practices alongside its flagship teaching hospital, the 178-bed Hunterdon Medical Center.
Competition appears to motivate the deal.
A merger with HMH would give the combined entity the scale to expand services and meet rising demand.
HMH’s Growing Footprint
Hackensack Meridian is one of the largest hospital operators in the state. The system has been active on the deal front.
Related: DETAILED NOTES ON COCAINE :
It launched a new center near a transit hub in April and opened a $40 million youth mental health facility in June. Flemington, where Hunterdon is headquartered, sits roughly an hour’s drive west of Edison.
CEO Robert Garrett said the system is “so excited” about the chance to partner with Hunterdon. “By coming together, we’ll be able to improve access to top-tier care, expand services and programs to the great communities that Hunterdon and HMH serve, and invest in research and technology that make it easier for patients to take control of their health.”
A Pattern That’s Raising Concerns
Hunterdon’s possible loss of independent status reflects a broader trend in New Jersey and nationally. The state’s hospital market has become increasingly consolidated over the past decade. Other deals are in the pipeline, including one announced earlier this year between RWJBarnabas Health and Englewood Health. Researchers have linked corporate provider ownership to decreased care quality and higher costs for patients, a pattern that makes these deals worth watching closely.
Hospital systems argue the mergers are necessary to build financial resilience needed to absorb expected cuts to federal healthcare funding under the current administration. Regulators will eventually have to weigh whether that trade-off benefits patients or just the bottom line.
